Adaptyv Biosystems Sàrl

Next-generation protein engineering

Swiss Startup - Adaptyv Biosystems Main Image

Proteins are the most advanced nanotechnology we know of. Engineered proteins such as new antibodies, enzymes, gene therapy vectors and motor proteins will be at the core of the biorevolution and change how we think about curing diseases, manufacturing products and designing new materials.
At Adaptyv Bio we're building a next-generation protein foundry. We combine advanced robotics, microfluidics and synthetic biology techniques to create fully automated protein engineering workcells that allow users to synthesize and test any protein they design.

Only registered users have access to funding information.
Please log in or register to continue. Registration is free.

19.09.2025

Adaptyv leaves the beta phase following its $8m seed round (startupticker.ch)

15.02.2024

Student VC Founderful Campus starts a new chapter (startupticker.ch)

01.06.2023

CHF 100'000 for Adaptyv Bio and Hexem (startupticker.ch)

17.04.2023

Adaptyv Bio launches its protein-engineering platform (startupticker.ch)

14.04.2022

S2S Ventures completes first investment deal (startupticker.ch)

15.03.2022

First Wingman Campus Fund supported startups revealed (startupticker.ch)

14.02.2022

Adaptyv Biosystems raises USD 2.5 million to create the world’s largest protein design database (venturekick.ch)

14.02.2022

CHF2.5 million to build up the most powerful protein engineering platform (startupticker.ch)

15.09.2021

CHF 40,000 for startups developing the next-generation of antibody engineering, enjoyable prosthetics, and antibodies for the treatment of Leukemia (venturekick.ch)

No milestones

Head of QC & Analytics

Engineering / Fulltime

Adaptyv is seeking a Head of QC & Analytics to lead quality control and data integrity across its high-throughput foundry. In this hands-on role, you will define the standards for "good data" and partner with software engineers to automate the processing and validation of thousands of simultaneous protein assays, including BLI and SPR. You will be responsible for building the scientific logic for anomaly detection, establishing SOPs within automated workcells, and ensuring that the millions of data points delivered to biopharma and AI customers are robust and reliable. The ideal candidate holds an advanced degree in Biochemistry or Biophysics with over 6 years of experience in protein science and a strong proficiency in Python or R for data processing. Joining Adaptyv offers the opportunity to shape the infrastructure of "agentic science," bridging the gap between frontier AI models and physical-world wet lab experimentation at a massive scale.

No videos and documents

Venture Kick

Venture Kick supports potential entrepreneurs with start capital up to CHF 150'000 as well as hands-on execution support and access to a nationwide network of investors and experts in the startup field. Multiple times per year, 8 selected projects get the opportunity to present their business ideas in front of a panel. The 5 most promising projects enter the support process. After 9 months at the latest, the startups incorporate and enter the market. Since 2007, Venture Kick has invested over CHF 58 million in over 1111 projects.

Venture Kick (50'000) 2021

Website